Market revenue in 2022 | USD 9,208.3 million |
Market revenue in 2030 | USD 14,063.1 million |
Growth rate | 5.4% (CAGR from 2022 to 2030) |
Largest segment | Oxygen source equipment |
Fastest growing segment | Oxygen Delivery Devices |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oxygen Source Equipment, Oxygen Delivery Devices |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Inogen Inc, Smiths Group PLC, Fisher & Paykel Healthcare Corp Ltd, Koninklijke Philips NV, Allied Healthcare Products Inc, Teleflex Inc, Chart Industries Inc, Draegerwerk AG & Co KGaA, Niterra Co Ltd, Invacare, Hersill, DeVilbiss Healthcare, Tecno-Gaz |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oxygen therapy market will help companies and investors design strategic landscapes.
Oxygen source equipment was the largest segment with a revenue share of 73.58% in 2022. Horizon Databook has segmented the U.S. oxygen therapy market based on oxygen source equipment, oxygen delivery devices covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. constituted a substantial share of the North America oxygen therapy market owing to increased demand for oxygen therapy due to the COVID-19 pandemic and a rise in the number of patients who were advised home isolation.
The U.S. FDA has issued an emergency use directive for portable oxygen cylinders. Owing to this, numerous market players in the medical devices industry have pushed manufacturers of U.S. oxygen therapy systems to increase the production of oxygen cylinders to meet rising demand.
Besides, key market players are focusing on strategies to improve their market penetration. For instance, in April 2022, CAIRE Inc. entered Brazil to expand its oxygen portfolio with the Companion 5 and New Life Intensity 10-liter stationary oxygen concentrators.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. oxygen therapy market , including forecasts for subscribers. This country databook contains high-level insights into U.S. oxygen therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account